FoxP3+ levels in CRC and NSCLC tumors were 1.7 and 3.5 times higher than other indications respectively (CRC 95%CI 1.04 to 2.82, NSCLC 95%CI 2.01 to 6.25). The gene discussed is FOXP3; the disease is non-small cell lung carcinoma.